Advanced Life Sciences Featured as Special Stock Pick by KonLin Investment Letter
CHICAGO, Aug. 5 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS ), a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced that the Company has been featured as a special stock pick for August, 2010 by "The KonLin Letter," a 27 year old independent, financial newsletter (www.konlin.com ). This is an unsolicited and unpaid evaluation of Advanced Life Sciences, performed by KonLin Research & Analysis.
Highlights from The KonLin Letter include:
- A recommendation "to accumulate positions for a 1st target of
$0.25 then $0.50, since the CDC has warned that
previously treatable diseases, such as pneumonia, are again
becoming untreatable due to the alarming growth in antibiotic
resistance." "Ultimate target <